MAIA
MAIA Biotechnology Inc (MAIA)
Healthcare • NYSE MKT • $1.09-1.36%
Key Fundamentals
- Symbol
- MAIA
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.09
- Daily Change
- -1.36%
- Market Cap
- $67.92M
- Trailing P/E
- N/A
- Forward P/E
- 0.99
- 52W High
- $3.19
- 52W Low
- $0.87
- Analyst Target
- $12.00
- Dividend Yield
- 0.00%
- Beta
- 0.28
About MAIA Biotechnology Inc
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Company websiteResearch MAIA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.